February 8, 2026

Background

Cristina Adriana Popa

To INFINITI and Beyond: SGLT2 Inhibitors in ...

This week, we aim for an INFINITe allograft lifespan. or flozination in kidney transplant.

January 26, 2026

Background

Cristina Adriana Popa

POTCAST- K+ Pop and Arrhythmia Drop

This week, we will discuss the POTCAST trial. It is a cardiology trial - but potassium belongs to nephrology.

January 11, 2026

Background

Brian Rifkin

A VALIANT effort to combat complement disorders ...

This week, we will discuss the VALIANT study, pegcetacoplan in C3G and IC MPGN.

January 3, 2026

news

Cristina Adriana Popa

Top Stories in Nephrology 2025

2025 was rich in successful stories. Here are the top 10 that impressed our audience.

December 15, 2025

Background

Brian Rifkin

Dialyze Less, Recover More? AKI’s Chance to Get ...

This week, we will discuss whether less is more when it comes to discontinuing dialysis in patients with AKI and a chance to recover.

prospective

swapnil hiremath

May 18, 2018

Background

Donating Organs & Drug Overdoses

swapnil hiremath

May 18, 2018

Background

The opioid epidemic is tragically providing a lot of organs for transplant. We are using more over-dose death organs than ever before. Do they measure up?

swapnil hiremath

January 26, 2018

Background

How I learned to stop worrying and love metformin

swapnil hiremath

January 26, 2018

Background

How I learned to stop worrying and love metformin

How long should we allow metformin to remain the bogeyman in CKD? Should MALA scare us from ever letting our patients benefit from metformin? Join us as we discuss some rare prospective data on metformin in moderate to severe CKD.